Cargando…
Inhaled CpG increases survival and synergizes with checkpoint inhibition in lymphangioleiomyomatosis
RATIONALE: Lymphangioleiomyomatosis (LAM) is a devastating disease primarily found in women of reproductive age that leads to cancer-like cystic destruction of the lungs. Recent work has shown that LAM causes immunosuppression and that checkpoint inhibitors can be used as LAM treatment. IN lung canc...
Autores principales: | Amosu, Mayowa M, McCright, Jacob C, Yang, Bennett E, de Oro Fernandez, Juan Grano, Moore, Kaitlyn A, Gadde, Havish S, Kaluzienski, Michele L, Maisel, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934559/ https://www.ncbi.nlm.nih.gov/pubmed/36798234 http://dx.doi.org/10.1101/2023.02.06.527331 |
Ejemplares similares
-
Targeting the Gut Mucosal Immune System Using Nanomaterials
por: McCright, Jacob, et al.
Publicado: (2021) -
Targeting Lymphatics for Nanoparticle Drug Delivery
por: McCright, Jacob, et al.
Publicado: (2022) -
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
por: Julier, Ziad, et al.
Publicado: (2016) -
CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8(+) T Cells
por: Cobb, Dustin, et al.
Publicado: (2013) -
Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma
por: Gershan, Jill A., et al.
Publicado: (2015)